World Journal of Cardiovascular Diseases
Volume 3, Issue 3 (June 2013)
ISSN Print: 2164-5329 ISSN Online: 2164-5337
Google-based Impact Factor: 0.38 Citations
Combined phosphodiesterase inhibitors in end-stage heart failure: A case presentation ()
Affiliation(s)
ABSTRACT
Heart failure (HF) is the leading cause of morbidity and mortality and is evolving to epidemic proportions. Despite pharmacologic advances and device interventions, HF remains a progressive disease. The phosphodiesterase inhibitors-3 (PDE3I), and more recently, the phosphodiesterase inhibitors-5 (PDE5I) have been used as part of the treatment in certain patients, however, such combination has not been studied or reported before.
KEYWORDS
Share and Cite:
Cited by
Copyright © 2024 by authors and Scientific Research Publishing Inc.
This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.